Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Bendstrup

Showing results (111-120 of 216) with videos related to

Pageof 22
Sort By:
Respiratory Medicine|June 15, 2021
Clusters of comorbidities in idiopathic pulmonary fibrosisThomas Skovhus Prior, Nils Hoyer, Ole Hilberg, et al.
Respiratory Research|March 9, 2023
Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trialMichael Kreuter, Elisabeth Bendstrup, Stéphane Jouneau, et al.
Diagnostics (Basel, Switzerland)|June 12, 2026
Senicapoc in Patients with Idiopathic Pulmonary Fibrosis or Other Progressive Fibrotic Interstitial Lung Diseases: Protocol for a Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II TrialLine Kølner-Augustson, Alan Altraja, Elisabeth Bendstrup, et al.
ERJ Open Research|January 28, 2025
Long-term outcomes in five patients with autoimmune pulmonary alveolar proteinosis treated with molgramostim inhalation solutionCelia Montaño, Elisabeth Bendstrup, Ida Rønnov-Jessen, et al.
Respiratory Research|July 8, 2021
Global incidence and prevalence of idiopathic pulmonary fibrosisToby M Maher, Elisabeth Bendstrup, Louis Dron, et al.
Ugeskrift for Laeger|June 5, 2013
[Pulmonary hypertension--classification, work-up and treatment]Charlotte Uggerhøj Andersen, Lene Dahl Sønderskov, Jens Erik Nielsen-Kudsk, et al.
BMC Pulmonary Medicine|December 21, 2019
Validation of the King's Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary FibrosisThomas Skovhus Prior, Ole Hilberg, Saher Burhan Shaker, et al.
Respiratory Research|April 27, 2021
Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbiditiesIan Glaspole, Francesco Bonella, Elena Bargagli, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 10, 2012
Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary diseaseKasper Hasseriis Andersen, Martin Iversen, Jesper Kjaergaard, et al.
BMC Pulmonary Medicine|December 11, 2023
The usual Interstitial pneumonia pattern in autoimmune rheumatic diseasesFabrizio Luppi, Andreina Manfredi, Paola Faverio, et al.
Pageof 22

Showing results (111-120 of 216) with videos related to

Sort By:
Pageof 22
Respiratory Medicine|June 15, 2021
Clusters of comorbidities in idiopathic pulmonary fibrosisThomas Skovhus Prior, Nils Hoyer, Ole Hilberg, et al.
Respiratory Research|March 9, 2023
Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trialMichael Kreuter, Elisabeth Bendstrup, Stéphane Jouneau, et al.
Diagnostics (Basel, Switzerland)|June 12, 2026
Senicapoc in Patients with Idiopathic Pulmonary Fibrosis or Other Progressive Fibrotic Interstitial Lung Diseases: Protocol for a Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II TrialLine Kølner-Augustson, Alan Altraja, Elisabeth Bendstrup, et al.
ERJ Open Research|January 28, 2025
Long-term outcomes in five patients with autoimmune pulmonary alveolar proteinosis treated with molgramostim inhalation solutionCelia Montaño, Elisabeth Bendstrup, Ida Rønnov-Jessen, et al.
Respiratory Research|July 8, 2021
Global incidence and prevalence of idiopathic pulmonary fibrosisToby M Maher, Elisabeth Bendstrup, Louis Dron, et al.
Ugeskrift for Laeger|June 5, 2013
[Pulmonary hypertension--classification, work-up and treatment]Charlotte Uggerhøj Andersen, Lene Dahl Sønderskov, Jens Erik Nielsen-Kudsk, et al.
BMC Pulmonary Medicine|December 21, 2019
Validation of the King's Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary FibrosisThomas Skovhus Prior, Ole Hilberg, Saher Burhan Shaker, et al.
Respiratory Research|April 27, 2021
Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbiditiesIan Glaspole, Francesco Bonella, Elena Bargagli, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 10, 2012
Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary diseaseKasper Hasseriis Andersen, Martin Iversen, Jesper Kjaergaard, et al.
BMC Pulmonary Medicine|December 11, 2023
The usual Interstitial pneumonia pattern in autoimmune rheumatic diseasesFabrizio Luppi, Andreina Manfredi, Paola Faverio, et al.
Pageof 22